Former Nycomed CSO to Head General Medicine Drug Discovery Unit of Takeda

October 24, 2012
Takeda Pharmaceutical announced on October 22 that Sham Nikam, former chief scientific officer (CSO) of Swiss-based Nycomed A/S, a group company of Takeda, assumed office on the same day as head of the Extra Value Generation & General Medicine Drug...read more